Consensus Statement on the Management of Cancer-Associated Thrombosis (CAT) in India: A Delphi-Based Study

Cancer-associated thrombosis (CAT) is a major cause of morbidity and mortality among cancer patients, who face a 4–9 fold higher risk of venous thromboembolism (VTE) compared to the general population. In India, CAT is undertreated due to cost, limited diagnostic access, and suboptimal prophylaxis, emphasizing on the need for India-specific recommendations, as also evidenced by findings of a recent KAP survey. This structured Delphi methodology was conducted to systematically evaluate current practices and generate context-specific recommendations on CAT management in India. A three-phase Delphi methodology was conducted with 24 experts in hematology, oncology, vascular surgery, and critical care. Thirty-two statements across seven domains—awareness, thromboprophylaxis, anticoagulant initiation, therapy duration, extended therapy, bleeding management, and special populations—were formulated through literature review and face-to-face discussion. Two rounds of online voting using the Welphi platform were conducted, with consensus defined as ≥80% agreement on a 5-point Likert scale. Consensus was achieved for 29 of 32 statements (90.6%). Key recommendations included routine use of Khorana score for ambulatory risk assessment, pharmacologic prophylaxis for hospitalized moderate- to high-risk patients, LMWH discontinuation 12 hours preoperatively and resumption 24 hours postoperatively, DOAC use for low bleeding-risk patients, and LMWH as the preferred agent in high bleeding-risk scenarios. Anticoagulation for 3–6 months was endorsed, with extension beyond 6 months for active malignancy and low bleeding risk. This Delphi consensus provides India-specific, evidence-informed guidance for CAT management. Adoption of these recommendations may improve risk stratification, standardize practice, and enhance patient outcomes nationwide.

Authors

Institutions

Publication Details

Journal
Indian Journal of Hematology and Blood Transfusion
Published
2026-11-19
DOI
https://doi.org/10.1007/s12288-026-02635-w
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Consensus Statement on the Management of Cancer-Associated Thrombosis (CAT) in India: A Delphi-Based Study

Abhay A. Bhave, Aby Abraham, Lallu Joseph, Tulika Seth et al.
Indian Journal of Hematology and Blood Transfusion
Venous Thromboembolism Diagnosis and Management
article

Consensus Statement on the Management of Cancer-Associated Thrombosis (CAT) in India: A Delphi-Based Study

Abhay A. Bhave, Aby Abraham, Lallu Joseph, Tulika Seth, M. Joseph John, Ketan Asawale, Ketan Modak, Velu Nair, Shashikant Apte, B. Koppikar Smruti, Ashish Bondia, Shailesh Singi, V. A. Arun, Raguram Sekhar, Ajay Sharma
article en

Abstract

Cancer-associated thrombosis (CAT) is a major cause of morbidity and mortality among cancer patients, who face a 4–9 fold higher risk of venous thromboembolism (VTE) compared to the general population. In India, CAT is undertreated due to cost, limited diagnostic access, and suboptimal prophylaxis, emphasizing on the need for India-specific recommendations, as also evidenced by findings of a recent KAP survey. This structured Delphi methodology was conducted to systematically evaluate current practices and generate context-specific recommendations on CAT management in India. A three-phase Delphi methodology was conducted with 24 experts in hematology, oncology, vascular surgery, and critical care. Thirty-two statements across seven domains—awareness, thromboprophylaxis, anticoagulant initiation, therapy duration, extended therapy, bleeding management, and special populations—were formulated through literature review and face-to-face discussion. Two rounds of online voting using the Welphi platform were conducted, with consensus defined as ≥80% agreement on a 5-point Likert scale. Consensus was achieved for 29 of 32 statements (90.6%). Key recommendations included routine use of Khorana score for ambulatory risk assessment, pharmacologic prophylaxis for hospitalized moderate- to high-risk patients, LMWH discontinuation 12 hours preoperatively and resumption 24 hours postoperatively, DOAC use for low bleeding-risk patients, and LMWH as the preferred agent in high bleeding-risk scenarios. Anticoagulation for 3–6 months was endorsed, with extension beyond 6 months for active malignancy and low bleeding risk. This Delphi consensus provides India-specific, evidence-informed guidance for CAT management. Adoption of these recommendations may improve risk stratification, standardize practice, and enhance patient outcomes nationwide.

Indian Journal of Hematology and Blood Transfusion
Apollo Hospitals (IN), Christian Medical College, Vellore (IN), Lilavati Hospital & Research Centre (IN), Paras Hospitals (IN), Christian Medical College (IN), INHS Asvini (IN), Apollo Hospitals (IN), Kokilaben Dhirubhai Ambani Hospital (IN), Sahyadri Hospital (IN), Pfizer (India) (IN), All India Institute of Medical Sciences (IN)
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon